Nilsson Stefan 4

What Happened

• Stefan Nilsson, President of Nobel Biocare and an officer of Envista Holdings Corp (NVST), was granted equity awards and had a small number of shares withheld to cover tax obligations. On Feb 25, 2026 he was awarded a total of 39,470 award-equivalent shares (7,605 RSUs, 13,845 performance share units at target, and 18,020 option-linked units per footnotes) and 182 shares of common stock were withheld to satisfy tax withholding, resulting in proceeds of $5,385 from that withholding. The awards were granted at $0 per share (typical for RSU/PSU/option grants); the 182-share disposition is a routine tax-withholding sale (a form of sale/disposition).

Key Details

• Transaction date: Feb 25, 2026; Form 4 filed Feb 27, 2026 (filing appears timely).
• Withheld sale: 182 shares at $29.59 = $5,385 (tax withholding to satisfy withholding obligations).
• Grants/awards: 7,605 RSUs; 13,845 PSUs (reported at target; payout could range 0–200% depending on performance); 18,020 option-linked awards — all reported as acquired at $0.
• Vesting/conditions (from footnotes): RSUs vest ratably over 3 years; PSUs vest based on 3‑year performance measures (payable 0–200%); the option-like award vests ratably over 3 years.
• Shares owned after the transactions: not specified in the provided filing.
• Transaction code: F indicates shares withheld for tax obligations; A indicates grant/award. No 10b5‑1 or late filing flag noted.

Context

• The tax-related sale of 182 shares is a routine cashless withholding to cover taxes on vesting—not a discretionary open-market sale. The larger items are grants/awards that vest over time (some contingent on performance) and do not represent an immediate purchase or sale of open-market shares. These awards signal compensation rather than an immediate trading view by the insider.